You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endometrial Adenocarcinoma

Showing 1 - 25 of 3,799
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer, Endometrial Adenocarcinoma Trial (Cadonilimab, Carboplatin, Cisplatin)

Not yet recruiting
  • Endometrial Cancer
  • Endometrial Adenocarcinoma
  • (no location specified)
Oct 7, 2023

Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma Trial in Canton (ACR-368, Gemcitabine,

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +2 more
  • Mobile, Alabama
  • +7 more
Jan 24, 2023

Endometrial Cancer, Endometrial Adenocarcinoma Trial in Guangzhou (Cadonilimab, Lenvatinib)

Not yet recruiting
  • Endometrial Cancer
  • Endometrial Adenocarcinoma
  • Guangzhou, China
    Sun Yat-sen University Cancer Cetntre
Apr 9, 2023

PTEN Expression in Functional and Pathological Endometrial

Completed
  • Endometrial Hyperplasia
  • Endometrial Adenocarcinoma
  • routine stain by H&E.
  • Sohag, Egypt
    Maisa Hashem Mohammed
Jul 13, 2022

Recurrent Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma Trial in

Recruiting
  • Recurrent Endometrial Adenocarcinoma
  • +8 more
  • Ipilimumab
  • Nivolumab
  • Iowa City, Iowa
  • +9 more
Jan 27, 2023

Endometrial Adenocarcinoma Trial in Helsinki (Comparison of adjuvant therapies)

Recruiting
  • Endometrial Adenocarcinoma
  • Comparison of adjuvant therapies
  • Helsinki, Finland
    Helsinki University Hospital
Dec 8, 2022

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting
  • Advanced Solid Tumor
  • +18 more
  • (no location specified)
Aug 10, 2022

Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

Recruiting
  • Deleterious BRCA1 Gene Mutation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2022

Endometrial Cancer, Endometrial Adenocarcinoma Trial in United States (Pembrolizumab, Paclitaxel, Carboplatin)

Completed
Has Results
  • Endometrial Cancer
  • Endometrial Adenocarcinoma
  • Mesa, Arizona
  • +5 more
Feb 17, 2022

Endometrial Atypical Hyperplasia, Endometrial Adenocarcinoma Trial in Shanghai, Hangzhou (Megestrol acetate and metformin,

Completed
Has Results
  • Endometrial Atypical Hyperplasia
  • Endometrial Adenocarcinoma
  • Megestrol acetate and metformin
  • Megestrol acetate
  • Shanghai, Shanghai, China
  • +4 more
Sep 10, 2021

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • +8 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +7 more
  • (no location specified)
Jul 15, 2023

Endometrial Adenocarcinoma, Endometrial Carcinoma, Lynch Syndrome Trial in United States (Genetic Counseling, Genetic Testing,

Active, not recruiting
  • Endometrial Adenocarcinoma
  • +3 more
  • Genetic Counseling
  • +3 more
  • Akron, Ohio
  • +8 more
Dec 2, 2022

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +4 more
  • Akt Inhibitor MK2206
  • Laboratory Biomarker Analysis
  • Boston, Massachusetts
  • +6 more
Jan 13, 2022

Liquid Biopsies and Tumor Molecular Profiling in Predicting

Recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +5 more
  • Biospecimen Collection
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 3, 2022

Recurrence Among Low Risk Endometrial Cancer Patients

Recruiting
  • FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
  • FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
  • Bilateral Salpingectomy with Oophorectomy
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Endometrial Cancer, Endometrial Tumors, Endometrial Adenocarcinoma Trial in Istra (Laparoscopic hysterectomy with sentinel lymph

Recruiting
  • Endometrial Cancer
  • +8 more
  • Laparoscopic hysterectomy with sentinel lymph node biopsy
  • Istra, Moscow Region, Russian Federation
    Department of Gynecologic Oncology, Moscow City Oncology Hospita
Oct 8, 2021

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Metastatic

Not yet recruiting
  • FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • (no location specified)
Sep 13, 2022

Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in United

Active, not recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +4 more
  • Computed Tomography
  • +5 more
  • Houston, Texas
  • +6 more
Dec 5, 2022

Endometrial Cancer, Serous Adenocarcinoma, Uterine Tumor Trial (Niraparib oral capsule)

Not yet recruiting
  • Endometrial Cancer
  • +2 more
  • Niraparib oral capsule
  • (no location specified)
Oct 31, 2022

Cytoreductive Surgery, Grade 3 Endometrial Endometrioid Adenocarcinoma, High Grade Serous Carcinoma Trial in Boston (PET/MRI

Not yet recruiting
  • Cytoreductive Surgery
  • +4 more
  • PET/MRI with radiotracer ([18F]- fluorodeoxyglucose) and a gadolinium-based contrast agent
  • Boston, Massachusetts
    Massachusetts General Hospital
May 21, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in

Recruiting
  • Recurrent Endometrial Carcinoma
  • +12 more
  • Houston, Texas
  • +1 more
Sep 22, 2022

Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in

Active, not recruiting
Has Results
  • Endometrial Adenosquamous Carcinoma
  • +9 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +18 more
Oct 15, 2022

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Endometrial Adenocarcinoma, Endometrial Carcinosarcoma Trial in United States (Nivolumab, BMS- 986205)

Active, not recruiting
  • Endometrial Adenocarcinoma
  • Endometrial Carcinosarcoma
  • Basking Ridge, New Jersey
  • +6 more
Nov 29, 2021